US FDA wants pipeline failure data to be shared, but there is no discussion in Europe
This article was originally published in SRA
Executive Summary
US Food and Drug Administration commissioner Margaret Hamburg is pushing hard for more openness from the industry to release information to potential competitors on the reasons why drugs fail.